NovaBridge Biosciences: cashflow_investing
| Value | {"amount": 30518000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0a2eea52-fe18-47b1-9ffb-97be4ba7dcd4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-20-124785Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/cashflow-investing/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0a2eea52-fe18-47b1-9ffb-97be4ba7dcd4
History
- supersedes {"unit": "CNY", "value": 212462000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities"} (evidence 0001193125-20-124785)